Physician profile
David P Murphy
NPI 1538123872
$10,084.71
in general payments reported to CMS, 2019-2025
43 companies · $1,891 in 2025
The $1,891 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,338 · 2020: $704 · 2021: $1,504 · 2022: $1,456 · 2023: $1,748 · 2024: $1,444 · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,083.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,118.54 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $989.82 | 2019-2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $864.04 | 2019-2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $859.85 | 2019-2025 | |
| Abbvie INC. | $714.42 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $624.36 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $496.02 | 2019-2024 | Aveed, Xiaflex, Edex |
| Pfizer INC. | $480.08 | 2019-2025 | |
| Antares Pharma, INC. | $413.74 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Endo USA, INC. | $411.18 | 2024-2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $378.23 | 2019-2023 | Rezum Generator |
| Blue Earth Diagnostics | $346.83 | 2019-2025 | Posluma |
| Urogen Pharma, INC. | $272.82 | 2021-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $220.69 | 2022-2025 | Pylarify |
| Amgen INC. | $200.81 | 2019-2023 | Prolia |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.